Investigating VUS, especially in ATM, is essential for understanding cancer predisposition mechanisms, developing targeted therapies and potentially recognizing ATM as BRCA3 due to its functional similarities with BRCA1/2. The gene discussed is BRCA1; the disease is cancer.